drug resistant epilepsy. Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable
Conditions
Interventions
Intervention 1: Intervention group:Patients with drug-resistant epilepsy who are not good candidates for epilepsy surgery or who do not want surgery or are waiting for surgery. In all patients, the ep
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: age>=18 y/o all of patients full filled ILAE criteria of drug-resistant epilepsy participants were not good candidate for epilepsy surgery and or they will not surgery or they waited for epilepsy surgery. obtaining signed consent
Exclusion criteria
Exclusion criteria: scalp diseases(such as eczema, skin lesions) previous intracranial surgery, intracranial metal (out of mouth) such as cracking, surgical clip implanted device such as cardiac pacemaker, VNS, Cochlear implantation recurrent or severe headaches previous head trauma and other related brain diseases pregnancy and lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Investigating changes in the frequency of epileptic seizures. Timepoint: before intervention and monthly for 3 months. Method of measurement: seizure diary.;Investigating the frequency changes of interictal epileptiform discharges. Timepoint: immediately before and after intervention and then monthly for 3 months. Method of measurement: 30 minutes standard EEG.;Side effects. Timepoint: immediately after stimulation. Method of measurement: specialist visit.;Quality of life. Timepoint: before intervention and after 3 months. Method of measurement: full filling of the QoL in Epilepsy Inventory-89. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSoheila Rezakhani
Kerman University of Medical Sciences
Outcome results
None listed